Диссертация (1174301), страница 26
Текст из файла (страница 26)
The destruction complex of beta-catenin in colorectalcarcinoma and colonic adenoma // Einstein (Sao Paulo). – 2016. – 14(2). – P.135-42.Bronner, M.P., Culin, C., Reed, J. C., Furth, E. E. The bcl-2 proto-oncogene andthe gastrointestinal epithelial tumor progression model // The American Journalof Pathology. – 1995.
– 146(1). – P. 20-26.Buda, A.et al. Prevalence of different subtypes of serrated polyps and risk ofsynchronous advanced colorectal neoplasia in average-risk population undergoingfirst-time colonoscopy // Clin Transl Gastroenterol. – 2012. – 3. – P. e6.Burgess, N.G.et al. Comparison of Large Sessile Serrated AdenomaCharacteristics With Conventional Advanced Mucosal Neoplasia Resected byWide Field Endoscopic Mucosal Resection in a Multicenter Prospective Cohort //Gastrointestinal Endoscopy. – 2013. – 77(5).
– P. AB157.Burgess, N.G., Tutticci, N. J., Pellise, M., Bourke, M. J. Sessile serratedadenomas/polyps with cytologic dysplasia: a triple threat for interval cancer //Gastrointest Endosc. – 2014. – 80(2). – P. 307-10.Bustamante-Balen, M., Bernet, L., Cano, R., Morell, L., Lopez, A. Assessing thereproducibility of the microscopic diagnosis of sessile serrated adenoma of thecolon // Rev Esp Enferm Dig. – 2009. – 101(4). – P. 258-64.Carr, N.J.et al.
Serrated and non-serrated polyps of the colorectum: theirprevalence in an unselected case series and correlation of BRAF mutationanalysis with the diagnosis of sessile serrated adenoma // J Clin Pathol. – 2009. –62(6). – P. 516-8.Chino, A.et al. The frequency of early colorectal cancer derived from sessileserrated adenoma/polyps among 1858 serrated polyps from a single institution //Int J Colorectal Dis. – 2016. – 31(2).
– P. 343-9.Chipuk, J.E. BCL-2 proteins: melanoma lives on the edge // Oncoscience. – 2015.– 2(9). – P. 729-730.Choi K. W., J.B.I., Eun J. R., Lee J. H., Bae Y. K., Kim T. N. Expression of βcatenin, hMLH1, p53, Bcl-2, Bax and COX-2 in Serrated Adenomas of Colon //Korean J Gastroentest Endosc. – 2007. – 34(1). – P. 19-27.Chung, S.M.et al. Serrated polyps with "intermediate features" of sessile serratedpolyp and microvesicular hyperplastic polyp: a practical approach to theclassification of nondysplastic serrated polyps // Am J Surg Pathol. – 2008.
–32(3). – P. 407-12.23745.46.47.48.49.50.51.52.53.54.55.56.57.58.59.60.Coleman, H.G.et al. Colorectal Cancer Risk Following Adenoma Removal: ALarge Prospective Population-Based Cohort Study // Cancer EpidemiolBiomarkers Prev. – 2015. – 24(9). – P. 1373-80.Coode, P.E., Chan K.W., and Chan Y.T. Polyps and diverticula of the largeintestine: a necropsy survey in Hong Kong // Gut. – 1985.
– 26(10). – P. 1045-8.Costantini, M.et al. Interobserver agreement in the histologic diagnosis ofcolorectal polyps. the experience of the multicenter adenoma colorectal study(SMAC) // J Clin Epidemiol. – 2003. – 56(3). – P. 209-14.Dabbs, D.J., Diagnostic Immunohistochemistry: Theranostic and GenomicApplications. 4th ed. 2014: Elsevier.Dai, H., Meng, X., Kaufmann, Scott. BCL2 Family, Mitochondrial Apoptosis,and Beyond // Cancer Translational Medicine.
– 2016. – 2(1). – P. 7-20.Dalerba, P.et al. CDX2 as a Prognostic Biomarker in Stage II and Stage III ColonCancer // N Engl J Med. – 2016. – 374(3). – P. 211-22.Davenport, A., Hale, R. J., Hunt, C. R., Bigley, G., McMahon, R. F. T.Expression of Ki-67 and cytokeratin 20 in hyperplastic polyps of the colorectum// Journal of Clinical Pathology.
– 2003. – 56(3). – P. 200-204.Dawson, H.et al. Possible role of Cdx2 in the serrated pathway of colorectalcancer characterized by BRAF mutation, high-level CpG Island methylatorphenotype and mismatch repair-deficiency // Int J Cancer. – 2014. – 134(10). – P.2342-51.Dayi N., B.H.A., Schmid K. W., Schmitz K. J. Increased expression of αmethylacyl-coenzyme A racemase (AMACR; p504s) and p16 in distalhyperplastic polyps // Diagn Pathol. – 2013. – 178(8).Denis, B.et al. Diagnostic accuracy of community pathologists in theinterpretation of colorectal polyps // Eur J Gastroenterol Hepatol. – 2009. –21(10).
– P. 1153-60.East, J.E., Saunders B.P., and Jass J.R. Sporadic and syndromic hyperplasticpolyps and serrated adenomas of the colon: classification, molecular genetics,natural history, and clinical management // Gastroenterol Clin North Am. – 2008.– 37(1). – P. 25-46, v.Eide, T.J. Risk of colorectal cancer in adenoma-bearing individuals within adefined population // Int J Cancer.
– 1986. – 38(2). – P. 173-6.Eide, T.J. and Stalsberg H. Polyps of the large intestine in Northern Norway //Cancer. – 1978. – 42(6). – P. 2839-48.Ensari, A.et al. Serrated polyps of the colon: how reproducible is theirclassification? // Virchows Arch. – 2012. – 461(5). – P. 495-504.Estrada, R.G.
and Spjut H.J. Hyperplastic polyps of the large bowel // Am J SurgPathol. – 1980. – 4(2). – P. 127-33.Euscher, E.D.et al. Large colorectal adenomas. An approach to pathologicevaluation // Am J Clin Pathol. – 2001. – 116(3). – P. 336-40.23861.62.63.64.65.66.67.68.69.70.71.72.73.74.75.Facciorusso, A.et al. Development and validation of a risk score for advancedcolorectal adenoma recurrence after endoscopic resection // World JGastroenterol. – 2016. – 22(26). – P. 6049-56.Farris, A.B.et al. Sessile serrated adenoma: challenging discrimination from otherserrated colonic polyps // Am J Surg Pathol.
– 2008. – 32(1). – P. 30-5.Ferlitsch, M.et al. Sex-specific prevalence of adenomas, advanced adenomas, andcolorectal cancer in individuals undergoing screening colonoscopy // Jama. –2011. – 306(12). – P. 1352-8.Flohil, C.C., Janssen P.A., and Bosman F.T. Expression of Bcl-2 protein inhyperplastic polyps, adenomas, and carcinomas of the colon // J Pathol. – 1996.
–178(4). – P. 393-7.Foss, F.A., Milkins S., and McGregor A.H. Inter-observer variability in thehistological assessment of colorectal polyps detected through the NHS BowelCancer Screening Programme // Histopathology. – 2012. – 61(1).
– P. 47-52.Fu, B.et al. Clinicopathologic and genetic characterization of traditional serratedadenomas of the colon // Am J Clin Pathol. – 2012. – 138(3). – P. 356-66.Fu, X.et al. Retained cell-cell adhesion in serrated neoplastic pathway as opposedto conventional colorectal adenomas // J Histochem Cytochem. – 2011. – 59(2). –P. 158-66.Fujimori, Y.et al. An assessment of the diagnostic criteria for sessile serratedadenoma/polyps: SSA/Ps using image processing software analysis for Ki67immunohistochemistry // Diagn Pathol. – 2012.
– 7. – P. 59.Fujita, K.et al. Sessile serrated adenoma with early neoplastic progression: aclinicopathologic and molecular study // Am J Surg Pathol. – 2011. – 35(2). – P.295-304.Fukuyama, R.et al. Mutated in colorectal cancer, a putative tumor suppressor forserrated colorectal cancer, selectively represses beta-catenin-dependenttranscription // Oncogene. – 2008. – 27(46). – P. 6044-55.Gelincik, I. Ki-67 and Bcl-2 in colorectal polyps with breast cancer // Indian JPathol Microbiol. – 2011. – 54(2). – P.
307-11.Georgescu, C.V.et al. Correlations of proliferation markers, p53 expression andhistological findings in colorectal carcinoma // J Gastrointestin Liver Dis. – 2007.– 16(2). – P. 133-9.Glatz, K.et al. A multinational, internet-based assessment of observer variabilityin the diagnosis of serrated colorectal polyps // Am J Clin Pathol. – 2007. –127(6). – P. 938-45.Goldstein, N.S.et al. Hyperplastic-like colon polyps that preceded microsatelliteunstable adenocarcinomas // Am J Clin Pathol. – 2003.
– 119(6). – P. 778-96.Guo, R.J.et al. The intestine-specific transcription factor Cdx2 inhibits betacatenin/TCF transcriptional activity by disrupting the beta-catenin-TCF proteincomplex // Carcinogenesis. – 2010. – 31(2). – P. 159-66.23976.77.78.79.80.81.82.83.84.85.86.87.88.89.90.Gurudu, S.R.et al. Sessile serrated adenomas: demographic, endoscopic andpathological characteristics // World J Gastroenterol. – 2010.
– 16(27). – P. 34025.Gurzu, S., Szentirmay, Z., Toth, E., Bara, T., Bara, T. Jr. and Jung I. SerratedPathway Adenocarcinomas: Molecular and Immunohistochemical Insights intoTheir Recognition // PLOS ONE. – 2013. – 8(3). – P. e57699.Hafezi-Bakhtiari, S.et al. Histological overlap between colorectalvillous/tubulovillous and traditional serrated adenomas // Histopathology. – 2015.– 66(2). – P.
308-13.Haramis, A.P.et al. De novo crypt formation and juvenile polyposis on BMPinhibition in mouse intestine // Science. – 2004. – 303(5664). – P. 1684-6.Hazewinkel, Y.et al. Prevalence of serrated polyps and association withsynchronous advanced neoplasia in screening colonoscopy // Endoscopy. – 2014.– 46(3). – P. 219-24.Hegazy A., D.S.A., Ibrahim W. S., El-Atrebi K., Saker M., Abdel-Wahab N. Roleof Ki-67, P53 and Bcl-2 in Advanced Colorectal Carcinoma (Histopathologicaland Immunohistochemical Study) // Academic Journal of Cancer Reseach. –2014. – 7(3).
– P. 168-72.Hemann, M. and Lowe S. The p53–Bcl-2 connection // Cell Death Differ. – 2006.– 13(8). – P. 1256-9.Hetzel, J.T.et al. Variation in the detection of serrated polyps in an average riskcolorectal cancer screening cohort // Am J Gastroenterol. – 2010. – 105(12). – P.2656-64.Higuchi, T., Sugihara K., and Jass J.R. Demographic and pathologicalcharacteristics of serrated polyps of colorectum // Histopathology.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
